Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "in-PharmaTechnologis" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about in-PharmaTechnologis for you to read. Along with our medical data and news we also list in-PharmaTechnologis Clinical Trials, which are updated daily. BioPortfolio also has a large database of in-PharmaTechnologis Companies for you to search.
Indivior has requested a temporary restraining order against Dr. Reddyâs Laboratories to prevent further sales of its generic buprenorphine and naloxone sublingual film product in the US.
Orion Contract Manufacturing will make, package, and supply Peptonic Medicalâs over-the-counter VagiVital product, which is set to launch later this year.
Axim Biotechnologiesâ âextremely efficientâ cannabinoid molecule extraction and purification method has received a US patent.
The Spanish National Police has uncovered three secret laboratories and seized âthousands of cartonsâ of counterfeit medicines, says Europol.
Adents has combined artificial intelligence and Microsoft Blockchain-based technology to help secure and analyse transactions across the supply chain.
A growing client base in the US and healthy demand for highly potent active pharmaceutical ingredients (HPAPIs) are driving expansion at the UK-based CDMO Sterling Pharma Solutions.
Mylan says âminor deficienciesâ in its abbreviated new drug application for its proposed generic version of GSKâs Advair Diskus have prompted the US FDA to issue a complete response letter.
The US FDA has rejected Valeant Pharmaceutical Internationalâs investigational topical treatment for plaque psoriasis, Duobrii.
DSP has released its generic Atorvastatin drug product within the EU with additional markets to be added later this year the firm looks to become a full-service generics company.
Sanofi is handing off its Holmes Chapel facility and all existing contract manufacturing agreements to CDMO Recipharm.
A lack of âbasic documentationâ and âdubiousâ environmental control system reports at Taiwan Biotechâs manufacturing plant were cited in the US FDA warning letter.
UK antibiotics maker Purogenix Ltd. has dismissed the majority of its employees and appointed two KPMG insolvency practitioners to manage its assets.
Oral tolerability concerns have prompted the US biotech to close Ph II clinical trial investigations of FLX-787 in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth (CMT).
The first candidate made in accordance with Chinaâs Marketing Authorisation Holder pilot programme has received new drug application approval.
Alcami began work on Flexion Therapeutics's ZILRETTA in the fall of 2014 and today announced that it will further support commercial supply of the product, which is approved for the treatment of OA-related knee pain.
Impending EU serialisation regulations could enhance drug recall procedures for pharmaceutical companies, says executive.
Cambrexâs news that it will be constructing a research and development laboratory at its Italy-based site follows on the heels of its recently announced plans to begin a $5m expansion in Sweden.
Sanofi Pasteur has teamed with Translate Bio to develop mRNA vaccines for infectious diseases, using a platform developed by subsidiaries of Shire plc.
The US Food and Drug Administration (FDA) is planning to reorganize its drug review office to make it 20% more efficient.
SIGA is slated to receive FDA approval for the worldâs first antiviral drug to treat smallpox â a milestone not reached in isolation, but in collaboration with several CROs, government agencies, and others.
Virpax Pharmaceuticals is developing a long-acting analgesic gel it says could reduce reliance on opioid pain management.
Blockchain is gaining momentum in the pharmaceutical industry, but consultant Pasi Kemppainen says he would be âcautiousâ to implement the technology across the entire digital supply chain.
Emergent BioSolutions has initiated a $50m multi-year expansion at the companyâs Baltimore, MD-based fill/finish facility.
The Centre for Process Innovation (CPI) has confirmed its role in a UK initiative to accelerate vaccine production and eliminate the need for cold-chain shipping.
Analytical testing concerns and âinadequateâ investigations into failed results were among the GMP deviations observed by the US FDA at IDT Australia Limitedâs facility.